<DOC>
	<DOCNO>NCT00607256</DOCNO>
	<brief_summary>To evaluate lon-term safety tolerability [ S , S ] -reboxetine patient fibromyalgia</brief_summary>
	<brief_title>Long-term OL Study S , S-RBX Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Diagnosis patient meet ACR criterion fibromyalgia ( i.e . widespread pain present least 3 month , pain least 11 18 specific tender point site ) Patients severe pain ( e.g . DPN PHN ) may confound assessment selfevaluation pain associate fibromyalgia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>